Immunization, Hib3 in Lebanon
Lebanon: Immunization, Hib3 was 51.0% in 2024. ▼ Falling
Immunization, Hib3 in Lebanon, 2003–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Lebanon stood at 51.0%. That is the lowest value across all 22 years on record.
That represents a change of down 7.3% on the previous year and down 40.0% over ten years.
Over the whole period, immunization, hib3 in Lebanon peaked at 85.0% in 2013 and was at its lowest, 51.0%, in 2024.
That places Lebanon 186th out of 191 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 22 years of available data.
Immunization, Hib3 in Lebanon, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2003 | 74.0% | — |
| 2004 | 75.0% | +1.4% |
| 2005 | 77.0% | +2.7% |
| 2006 | 78.0% | +1.3% |
| 2007 | 80.0% | +2.6% |
| 2008 | 81.0% | +1.2% |
| 2009 | 82.0% | +1.2% |
| 2010 | 83.0% | +1.2% |
| 2011 | 83.0% | +0.0% |
| 2012 | 84.0% | +1.2% |
| 2013 | 85.0% | +1.2% |
| 2014 | 85.0% | +0.0% |
| 2015 | 85.0% | +0.0% |
| 2016 | 85.0% | +0.0% |
| 2017 | 85.0% | +0.0% |
| 2018 | 85.0% | +0.0% |
| 2019 | 85.0% | +0.0% |
| 2020 | 73.0% | -14.1% |
| 2021 | 69.0% | -5.5% |
| 2022 | 69.0% | +0.0% |
| 2023 | 55.0% | -20.3% |
| 2024 | 51.0% | -7.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 78.1% | 74.0% | 82.0% | 7 |
| 2010s | 84.5% | 83.0% | 85.0% | 10 |
| 2020s | 63.4% | 51.0% | 73.0% | 5 |
Countries ranked near Lebanon
- 184 Afghanistan 59.0% compare
- 184 Bolivia, Plurinational State of 59.0% compare
- 186 Azerbaijan 51.0% compare
- 188 Central African Republic 42.0% compare
- 188 Papua New Guinea 42.0% compare
- 188 Yemen 42.0% compare
More health data for Lebanon
- Un projection of annual infant deaths, annual growth rate -2.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.46 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,106 deaths per 1,000 people (2090)
- Number of infants who die before age 1 185 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.5482 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.209 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2024)
Frequently asked questions
- What is immunization, hib3 in Lebanon?
- Immunization, hib3 in Lebanon was 51.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Lebanon?
- The highest recorded value was 85.0% in 2013.
- What is the lowest immunization, hib3 recorded in Lebanon?
- The lowest recorded value was 51.0% in 2024.
- How does Lebanon rank for immunization, hib3?
- Lebanon ranks 186th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Lebanon?
- Over the last ten years it is down 40.0%. The long-run trend across the full record is falling.
- Where does this Lebanon data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.